Metraipolis › archive › dc_4eaad9011017
Cell secretome as a potential anticancer therapeutic agent: composition, mechanisms, preclinical evidence, and translational challenges — Europe PMC PMID:41858371
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41858371
- DOI
- 10.3389/fonc.2026.1729022
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T03:14:23.919Z
- SHA-256 of the archived text
fcc99a793915b091781327ae46416a34eae2d581e259cf82e69b9b58eaa872fc- Stable URL of this page
https://metraipolis.com/documento/dc_4eaad9011017
How to cite
Cell secretome as a potential anticancer therapeutic agent: composition, mechanisms, preclinical evidence, and translational challenges — Europe PMC PMID:41858371 — Europe PMC (en), https://europepmc.org/article/MED/41858371 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4eaad9011017 (Metraipolis archive dc_4eaad9011017, sha256 fcc99a793915b091781327ae46416a34eae2d581e259cf82e69b9b58eaa872fc)
BibTeX
@misc{dc4eaad9011017,
title = {Cell secretome as a potential anticancer therapeutic agent: composition, mechanisms, preclinical evidence, and translational challenges — Europe PMC PMID:41858371},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41858371},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4eaad9011017; sha256 fcc99a793915b091781327ae46416a34eae2d581e259cf82e69b9b58eaa872fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41858371. Agents can read the archived copy with the MCP tool read_document.